The battle to control prostate cancer has progressed in leaps and bounds in recent years. Nonetheless, significant challenges remain.
by Dr. Peter Black
Staying informed helps you plan your journey and stay on course
Prostate cancer is the most common cancer and the third leading cause of cancer death in men in Canada. Men need to know the facts about this disease and about their individual risk.
by Dr. Tom Pickles
Where are we now, and what’s the next step?
Some 16 years after randomized trials of PSA screening commenced in Europe and the US, many people anticipated that they would provide “the definitive answer” to this thorny issue. Both trials published their preliminary findings in the March 26, 2009 issue of the New England Journal of Medicine, and the results are apparently conflicting. This article helps interpret the studies (the full texts are available on the NEJM website at http://content.nejm.org).